

Publisher: Spandidos Publications
E-ISSN: 1791-3004|11|4|2689-2694
ISSN: 1791-2997
Source: Molecular Medicine Reports, Vol.11, Iss.4, 2015-01, pp. : 2689-2694
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Piperlonguminine (PL), a key compound from the Piper longum fruit, is known to exhibit antitumor and antiinflammatory activities. However, little is known about its effects on collageninduced arthritis (CIA). Fibroblastlike synoviocytes (FLS) have a pivotal role in the development of rheumatoid arthritis (RA). Myeloidderived suppressor cells (MDSCs) are able to suppress T cell responses and have important roles in the regulation of autoimmune arthritis. The current study investigated whether PL alters the progression of RA. It was determined that PL reduces the arthritis score and histopathologic lesions in a mouse model of CIA. PL also reduces the expression levels of serum anticollagen II antibodies (antiC), tumor necrosis factorα (TNFα), interleukin (IL)1β, IL23 and IL17 in CIA mice. In draining lymph nodes (DLNs), MDSCs were significantly expanded, however, the number of Th17 cells was markedly decreased by PL treatment. Additionally, PL reduced secretion of IL1β, IL23 and IL17 by TNFαstimulated human RA FLS. PL significantly inhibited the migration and invasion of TNFαstimulated human RA FLS. These results indicate that PL may be a candidate therapeutic agent for the treatment of RA, via the expansion of MDSCs and the inhibition of the Th17 response and activation of FLS.
Related content




Increased monocytic CD14+HLADRlow/- myeloid-derived suppressor cells in obesity
Molecular Medicine Reports, Vol. 11, Iss. 3, 2015-01 ,pp. :



